Frontiers in Oncology (Dec 2015)

Treatment parameters optimization to compensate for interfractional anatomy variability and intrafractional tumor motion

  • Romain eBrevet,
  • Daniel eRichter,
  • Christian eGraeff,
  • Marco eDurante,
  • Christoph eBert,
  • Christoph eBert

DOI
https://doi.org/10.3389/fonc.2015.00291
Journal volume & issue
Vol. 5

Abstract

Read online

Scanned ion beam therapy of lung tumors is severely limited in its clinical applicability by intrafractional organ motion, interference effects between beam and tumor motion (interplay) as well as interfractional anatomic changes. To compensate for dose deterioration by intrafractional motion, motion mitigation techniques, such as gating, have been developed. However, optimization of the treatment parameters is needed to further improve target dose coverage and normal tissue sparing. The aim of this study was to determine treatment planning parameters that permit to recover good target coverage and homogeneity for each fraction of lung tumor treatments. For 9 lung tumor patients from MD Anderson Cancer Center (Houston, Texas), a total of 70 weekly time-resolved computed tomography (4DCT) datasets were available, which depict the evolution of the patient anatomy over the several fractions of the treatment. Using the GSI in-house treatment planning system TRiP4D, 4D simulations were performed on each weekly 4DCT for each patient using gating and optimization of a single treatment plan based on a planning CT acquired prior to treatment. The impact on target dose coverage (V95) of variations in focus size and length of the gating window, as well as different additional margins and the number of fields was analyzed.It appeared that interfractional variability could potentially have a larger impact on V95 than intrafractional motion. However, among the investigated parameters, the use of a large beam spot size, a short gating window, additional margins and multiple fields permitted to obtain average V95 of 96.5%. In the presented study, it was shown that optimized treatment parameters have an important impact on target dose coverage in the treatment of moving tumors. Indeed, intrafractional motion occurring during the treatment of lung tumors and interfractional variability were best mitigated using a large focus, a short gating window, additional margins and three fields.

Keywords